Why Ero Copper (ERO) Might be Well Poised for a Surge
https://www.zacks.com/stock/news/2276241/why-ero-copper-ero-might-be-well-poised-for-a-surge?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_8-2276241
May 20, 2024 - Ero Copper (ERO) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
0
Tapestry's (TPR) Strategic Expansion & Innovation Bode Well
https://www.zacks.com/stock/news/2276266/tapestry-s-tpr-strategic-expansion-innovation-bode-well?cid=CS-ZC-FT-analyst_blog|rank_focused-2276266
May 20, 2024 - Tapestry's (TPR) growth strategy and focus on digital transformation set a positive trajectory for the company in the competitive luxury retail sector.
0
Genetics may determine who responds well to Wegovy: report
https://seekingalpha.com/news/4108409-genetics-may-determine-who-responds-well-to-wegovy-report?source=feed_sector_healthcare
May 20, 2024 - Certain patients appear to respond better to Novo Nordisk’s (NVO) weight-loss drug Wegovy than others due their genetic profiles, according to a new study. Read more here.
0
Barclays: Well On Track To Deliver On The Triple-Digit Upside
https://seekingalpha.com/article/4694438-barclays-well-on-track-to-deliver-on-the-triple-digit-upside?source=feed_all_articles
May 19, 2024 - Taking a longer-term perspective, Barclays has guided plans to generate GBP30 billion in revenue by 2026. Read why BCS stock is a Strong Buy.
0
Griffon: Well Positioned For Future Growth
https://seekingalpha.com/article/4694417-griffon-well-positioned-for-future-growth?source=feed_all_articles
May 19, 2024 - Griffon Corp's near-term topline decline due to weak demand in the CPP segment, but residential door volume growth should balance this.
0
Why Centerra Gold (CGAU) Might be Well Poised for a Surge
https://www.zacks.com/stock/news/2275640/why-centerra-gold-cgau-might-be-well-poised-for-a-surge?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_8-2275640
May 17, 2024 - Centerra Gold (CGAU) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
0
Why Super Group (SGHC) (SGHC) Might be Well Poised for a Surge
https://www.zacks.com/stock/news/2275005/why-super-group-sghc-sghc-might-be-well-poised-for-a-surge?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_8-2275005
May 16, 2024 - Super Group (SGHC) (SGHC) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
0
Do Boston Beer's (SAM) Strategies Position It Well Among Peers?
https://www.zacks.com/stock/news/2275038/do-boston-beer-s-sam-strategies-position-it-well-among-peers?cid=CS-ZC-FT-analyst_blog|rank_focused-2275038
May 16, 2024 - Boston Beer (SAM) is likely to retain its long-standing market position with its solid brand portfolio, the Beyond Beer strategy, innovation and pricing actions amid a troubled hard seltzer category.
0
Wells Fargo starts Wave Life Sciences at buy, cites valuation
https://seekingalpha.com/news/4106796-wells-fargo-starts-wave-life-sciences-at-buy-cites-valuation?source=feed_sector_healthcare
May 15, 2024 - Wells Fargo has initiated coverage of Wave Life Sciences (WVE) with an overweight rating, citing valuation and multiple upcoming catalysts. Read more here.
0
Why RCM Technologies (RCMT) Might be Well Poised for a Surge
https://www.zacks.com/stock/news/2274381/why-rcm-technologies-rcmt-might-be-well-poised-for-a-surge?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_8-2274381
May 15, 2024 - RCM Technologies (RCMT) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
0